The recent Annual Meeting of The Menopause Society brought to light significant advancements in understanding menopausal hormone therapy (MHT). Key areas of exploration included the neuroprotective potential of MHT, alongside its roles in managing weight and cardiovascular health.

Influence of Timing on Alzheimer’s Disease Biomarkers

Research presented delved into the timing of hormone therapy in relation to Alzheimer’s disease biomarkers, suggesting a potential link that could influence future treatment strategies.

Combining Hormone Therapy with Tirzepatide

Recent studies examined the efficacy of combining hormone therapy with tirzepatide, a dual GLP-1/GIP agonist that is revolutionizing obesity management. This combination could provide new avenues for treatment in midlife women.

Estetrol: Phase 3 Evidence

The phase 3 E4COMFORT II trial investigated estetrol, a selective estrogen receptor modulator praised for its lack of effect on blood pressure, even in women at higher cardiovascular risk.

This finding represents a significant advancement for postmenopausal women seeking effective menopause management without the risk of hypertension.

Test Your Knowledge

To further engage with these findings, consider taking a quick quiz that tests your understanding of the latest research outcomes. This is a valuable tool for healthcare professionals managing midlife women or anyone interested in staying updated on women’s health advancements.